key: cord-0769176-80inl3qb
authors: Parry, Arshed Hussain; Wani, Abdul Haseeb; Yaseen, Mudasira
title: Pulmonary embolism in coronavirus disease-19 (COVID-19): rational and stepwise use of clinical data and imaging in its diagnosis
date: 2020-07-28
journal: Clin Transl Imaging
DOI: 10.1007/s40336-020-00380-2
sha: 8fa6d641fec7acc2d419ca637889cd1d21b54a02
doc_id: 769176
cord_uid: 80inl3qb

nan

absence of PE. Two widely applied diagnostic modalities of chest radiography and non-contrast computed tomography (CT) of lungs in COVID-19 are also non-specific and cannot be relied upon to establish a diagnosis of PE. Among the imaging modalities, CT angiography (CTA) has the potential to conclusively confirm or refute the diagnosis of PE. Most of the published data until date on PE in COVID-19 pneumonia has primarily focused on and used CTA to arrive at the diagnosis. However, the use of CTA for diagnosis of PE may not be logistically feasible in every centre in the current pandemic for a multitude of reasons. First, it requires administration of iodinated contrast material which might be contraindicated in patients with acute kidney injury and contrast allergy. Acute kidney injury has been reported in COVID-19. Cheng et al. reported proteinuria and hematuria in admitted patients of COVID-19 with a frequency of 43.9 and 26.7%, respectively [4] . They also reported elevated creatinine and reduced glomerular filtration rate (< 60 ml/ min/1.73 m 2 ) in 14.4 and 13.1%, respectively. Administration of contrast may precipitate contrast induced nephropathy (CIN) in these patients. The risk of CIN may be further accentuated in severe COVID-19 patients with presence of shock, dehydration, acute tubular necrosis, and direct renal dysfunction by COVID-19. Second, the performance of CTA is logistically challenging, as it involves transfer of the patient from emergency room (ER) or intensive care unit (ICU), and some of the patients are too unstable to be transferred to CT suite. It also requires thorough disinfection of CT suite to prevent transmission of disease to uninfected patients.

Thus, it is essential to adopt a rational, systematic clinical, and stepwise radiologic approach for timely detection of PE. Clinical indicators of PE include hemoptysis, respiratory worsening, and sudden onset unexplained tachycardia and hypotension. Elevated D-dimer levels and electrocardiography are the preliminary investigations to be undertaken. These may be helpful to suggest a diagnosis of PE. D-dimer is an acute phase reactant and is usually elevated in severe COVID-19 cases which limits its utility as a screening test for venous thromboembolism because, although it has a high sensitivity, its specificity is poor. Nonetheless, D-dimer has a high negative predictive value for thromboembolic disease.

The findings of two widely used imaging modalities of chest radiography and non-contrast CT are non-specific for PE. In patients with hemodynamic instability and clinical suspicion of PE, features of right heart dysfunction or failure on echocardiography in combination with raised levels of brain natriureteric peptide may help to diagnose large pulmonary vessel thrombosis. The role of ventilation-perfusion scan in diagnosing PE in COVID-19 is limited as COVID-19 pneumonia is frequently associated with pathological imaging findings. According to Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED), a lung scintigraphy is considered non-diagnostic in the setting of a pathologic chest imaging and concurrent ventilation defect [5] .

There are limited data on the rate of occurrence of deep venous thrombosis (DVT) in COVID-19 patients with PE. Zhang [7] .

According to PIOPED II the majority (up to 90%) of PE originate in the deep venous system of lower extremities, reinforcing the fact that PE and DVT are the manifestations of a single pathological process [7] . Conversely, up to 50-70% patients of documented PE show evidence of lower extremity DVT when evaluated. Furthering the projections of PIOPED II, it is expected that a significant proportion of COVID-19 cases with PE would have an underlying DVT. Therefore, CTA should be prefaced with the use of compression ultrasound of lower limbs in ER or ICU. Patients with positive compression ultrasound can be started on anticoagulants without further need of CTA [8] . According to the PIOPED II, this group of PE patients may be as high as 50-70% [7] . However, further studies on prevalence of venous thromboembolism in COVID-19 in varied ethnic populations will help in streamlining the diagnostic pathway for PE in COVID-19.

Patients with high suspicion of PE with normal compression ultrasound will warrant further testing in the form of CTA. Patients with a preserved renal function can be subjected to CTA without any special concerns. However, patients with a deranged renal function must be prepared to mitigate the risk of CIN. This would entail adequate hydration and administration of a low dose of non-ionic low osmolar or iso-osmolar contrast to reduce the risk of CIN. Necessary precautions must be exercised during transfer of patient to CT suite and subsequent performance of CTA to reduce the risk of cross infection.

A diagnostic algorithm for diagnosis of PE in COVID-19 is summarized in Fig. 1 . This stepwise diagnostic imaging approach of prefacing CTA with compression ultrasound in ER or ICU and supplementary use of echocardiography in selected cases has the advantages of feasibility, rapidity, wide availability, and safety. In addition, the use of ultrasound would circumvent the process of transfer of patient outside ER or ICU which may be logistically difficult. 

Conflict of interest Authors declare that they have no conflict of interest.

Ethical approval This article does not contain any studies with human or animal participants performed by any of the authors.

Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China

Kidney disease is associated with in-hospital death of patients with COVID-19

Sostman HD (2006) Multidetector computed tomography for acute pulmonary embolism

Deep vein thrombosis in hospitalized patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: prevalence, risk factors, and outcome

Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19)

Pulmonary embolism in coronavirus disease-19 (COVID-19) and use of compression ultrasonography in its optimal management